ORTHO SINA
ActiveSummary
ORTHO SINA has been active since 2007 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €999k and a net result of €56k. Equity is growing by ~8.5% per year across the filed fiscal years. Its solvency ranks better than 76% of 8001 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 1.0% (low).
Checked score
Score 2025
76
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability74▼-10
Solvency96▲+7
Growth52▼-26
Track record100
Bankruptcy probability, 12 months
1.0%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €75k at 30 days acceptable
Liquidity ample (current ratio 3.29 against 2.6 in 2024; short-term debt: 15.7% and cash: 15.7% of total assets), and 29.3% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
70.7%
Return on assets
4%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Sector 46
higher
← fewer bankruptcies
more bankruptcies →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-07-2026, 7 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
7 d early
2024
28 d late
2023
29 d late
2022
24 d early
2021
31 d late
2020
26 d late
2019
63 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€999k▲ 5.9%
2024 · €943k
2018: €594k
2019: €617k
2020: €674k
2021: €709k
2022: €825k
2023: €967k
2024: €943k
2018 → 2025
Total assets
€1.41M▼ 3.6%
2024 · €1.46M
2018: €1.18M
2019: €1.15M
2020: €1.14M
2021: €1.36M
2022: €1.37M
2023: €1.47M
2024: €1.46M
2018 → 2025
Net result
€56k▼ 67.9%
2024 · €174k
2018: €136k
2019: €136k
2020: €102k
2021: €98k
2022: €54k
2023: €141k
2024: €174k
2018 → 2025
Working capital
€507k▲ 10.9%
2024 · €458k
2018: €451k
2019: €451k
2020: €486k
2021: €327k
2022: €425k
2023: €516k
2024: €458k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€709k-€825k▲ 16.3%€967k▲ 17.1%€943k▼ 2.4%€999k▲ 5.9%
Operating result€123k-€82k▼ 33.4%€212k▲ 158%€267k▲ 26.0%€84k▼ 68.7%
Net result€98k-€54k▼ 45.3%€141k▲ 164%€174k▲ 23.3%€56k▼ 67.9%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 69% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.41M
Fixed assets
€683k ▼ 5.2%
Current assets
€729k ▼ 1.9%
Equity and liabilities €1.41M
Equity
€999k ▲ 5.9%
Debt
€413k ▼ 20.7%
Debt's share of the balance-sheet total falls from 35.6% to 29.3%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€128k▼
2024 · €311k
Cash flow
€100k▼
2024 · €218k
Current ratio
3.29▲
2024 · 2.60
Quick ratio
3.11▲
2024 · 2.44
Debt to equity
0.41▼
2024 · 0.55
ROE
5.6%▼
2024 · 18.5%
ROA
4.0%▼
2024 · 11.9%
Interest coverage
7.71▼
2024 · 15.94
Debt ≤ 1 year
€222k▼
2024 · €286k
Debt > 1 year
€166k▼
2024 · €234k
Income taxes
€25k▼
2024 · €90k
Staff costs
€135k▼
2024 · €176k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 56 lines
Balance sheet
Code20242025
Assets
Total assets20/58€1.46M€1.41M▼
Fixed assets21/28€721k€683k▼
Tangible fixed assets22/27€720k€682k▼
Land and buildings22€695k€654k▼
Plant, machinery and equipment23€206€5k▲
Furniture and vehicles24€9k€5k▼
Other tangible fixed assets26€15k€18k▲
Financial fixed assets28€1k€1k=
Current assets29/58€743k€729k▼
Stocks and contracts in progress3€47k€41k▼
Stocks30/36€47k€41k▼
Amounts receivable within one year40/41€320k€336k▲
Trade receivables40€131k€102k▼
Other amounts receivable41€189k€233k▲
Current investments50/53€129k€129k=
Cash at bank and in hand54/58€246k€222k▼
Deferred charges and accrued income490/1€3k€2k▼
Equity and liabilities
Total equity and liabilities10/49€1.46M€1.41M▼
Equity10/15€943k€999k▲
Contributions10/11€77k€77k=
Reserves13€705k€761k▲
Distributable reserves133€705k€761k▲
Profit (loss) carried forward14€161k€161k=
Amounts payable17/49€521k€413k▼
Amounts payable after more than one year17€234k€166k▼
Financial debts170/4€234k€166k▼
Amounts payable within one year42/48€286k€222k▼
Current portion of amounts payable after more than one year42€65k€67k▲
Trade debts44€45k€15k▼
Suppliers440/4€45k€15k▼
Advances received on contracts in progress46€3k€5k▲
Taxes, remuneration and social security45€174k€135k▼
Taxes450/3€153k€120k▼
Remuneration and social security454/9€21k€15k▼
Accrued charges and deferred income492/3€2k€26k▲
Income statement
Code20242025
Remuneration, social security and pensions62€176k€135k▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€44k€44k▲
Other operating charges640/8€12k€17k▲
Gross operating margin9900€498k€279k▼
Operating profit (loss)9901€267k€84k▼
Financial income75/76B€17k€14k▼
Recurring financial income75€17k€14k▼
Financial charges65/66B€19k€17k▼
Recurring financial charges65€19k€17k▼
Profit (loss) for the period before taxes9903€265k€81k▼
Income taxes67/77€90k€25k▼
Profit (loss) for the period9904€174k€56k▼
Profit (loss) for the period to be appropriated9905€174k€56k▼
Appropriation of the result
Profit (loss) to be appropriated9906€335k€217k▼
Profit (loss) brought forward from the previous period14P€161k€161k=
Transfer from equity791/2€198k-
Transfer to equity691/2€174k€56k▼
To other reserves6921€174k€56k▼
Profit to be distributed694/7€198k-
Return on contributions (dividend)694€198k-
Social balance
Average headcount (FTE)90872.01.8▼
The notes to these accounts (13 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
24-07
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
28-08
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema · 28 days late
2024
31-12
Financial
Highest result since 2018net €174k ▲23.3%
Operating result €267k, net result €174k, both a record.
29-08
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema · 29 days late
2023
07-07
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
31-12
Financial
Weakest financial yearnet €54k ▼45.3%
Net result drops to €54k, the lowest in the series; recovery starts the following year.
31-08
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema · 31 days late
2021
26-08
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 26 days late
2020
02-10
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 63 days late
2019
30-08
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 30 days late
2018
22-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 22 days late
2017
26-06
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
5 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Jette · 2 establishment units since 2007
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Oude-Afspanningsplein 21090 JetteGround area
2,888 m²
Building footprint
2,188 m²
Volume, LiDAR
33,741 m³
2 parcels, Brussels, Wallonia · tallest building 18.7 m, ±5 floors. Linked by address, not a title deed.
2 establishment units
ORTHO SINA
since 20072.163.286.476
Esplanade De Cuyper-Beniest 5, 4671 Visé
since 20242.375.040.545
2 parcels
Wallonia
1
(50%)
Brussels
1
(50%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 62095C0028/00A004 | Wallonia | 2,736 m² | 1 · 2,065 m² | 18.6 m · 5 fl. |
| 21010B0019/00W016 | Brussels | 152 m² | 1 · 123 m² | 14.2 m · 4 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2023 · 1 entry · 20 EUR awarded · 20 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2023 | 1 | 20 EUR | 20 EUR |
Schemes
Hulpmiddelen voor personen met een beperkte mobiliteit
Recognitions · licences · registrations
Care and welfare
1 serviceORTHO SINA
Similar companies · same sector, comparable size
REVIMEX
BE 0443.312.566
Pelt · Eq €1,000,000
SEPTODONT NV-SA
BE 0415.827.815
Ganshoren · Eq €996,232
DIMED MEDICAL ENGINEERING
BE 0451.042.674
Antwerpen · Eq €1,003,514
AIP Medical
BE 0450.686.744
Olne · Eq €1,005,733
BIOTECHNOLOGICAL ENZYMATIC CATALYSE
BE 0446.755.472
Merelbeke-Melle · Eq €1,006,816
Of 1,898 companies in sector 46460 we hold annual accounts for 1,116. 758 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded06-06-2007
Fiscal year end31-12
Activities, NACEBEL 2025
46460Wholesale of pharmaceutical and medical goods
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
Sources
Crossroads Bank for EnterprisesNational Bank · 18 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.